Serotonin polymorphisms and posttraumatic stress disorder in a trauma exposed African American population

Depression and Anxiety

Volumn 26, Issue 11, 2009, Pages 993-997

  Mellman, Thomas A ^a   Alim, Tanya ^a   Brown, Denver D ^a   Gorodetsky, Elena ^b   Buzas, Beata ^b   Lawson, William B ^a   Goldman, David ^b   Charney, Dennis S ^c  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

5HT2A; 5HTTLPR; African American; Genetic variation; Trauma

Indexed keywords

SEROTONIN; SEROTONIN 2A RECEPTOR;

ADULT; AFRICAN AMERICAN; ASSAULT; COMORBIDITY; CONFERENCE PAPER; CONTROLLED STUDY; DEPRESSION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; POSTTRAUMATIC STRESS DISORDER; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROMOTER REGION; SEXUAL CRIME;

ADULT; AFRICAN AMERICANS; ALLELES; CASE-CONTROL STUDIES; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; STRESS DISORDERS, POST-TRAUMATIC; YOUNG ADULT;

EID: 70350719343     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20627     Document Type: Conference Paper

References (38)

1. Kessler RC, Sonnega A, Bromet E, et al. Posttraumatic stress disorder in the National Comorbidity Survey. Arch Gen Psychiatry 1995;52:1048-1060.
2. Koenen KC. Genetics of posttraumatic stress disorder: review and recommendations for future studies. J Trauma Stress 2007;20:737-750. (Pubitemid 350144881)
3. True WR, Rice J, Eisen SA, et al. A twin study of genetic and environmental contributions to liability for posttraumatic stress symptoms. Arch Gen Psychiatry 1993;50:257-264. (Pubitemid 23115368)
4. Institute of Medicine (U.S.). Committee on treatment of posttraumatic stress disorder. Treatment of posttraumatic stress disorder: an assessment of the evidence. Washington, DC: National Academies Press; 2008.
5. Meltzer HY, Matsubara S, Lee JC. Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. J Pharmacol Exp Ther 1989;251:238-246. (Pubitemid 19261970)
6. Bartzokis G, Lu PH, Turner J, et al. Adjunctive risperidone in the treatment of chronic combat-related posttraumatic stress disorder. Biol Psychiatry 2005;57:474-479. (Pubitemid 40311981)
7. Stein MB, Kline NA, Matloff JL. Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study. Am J Psychiatry 2002;159:1777-1779.
8. Gillin JC, Smith-Vaniz A, Schnierow B, et al. An open-label, 12-week clinical and sleep EEG study of nefazodone in chronic combat-related posttraumatic stress disorder. J Clin Psychiatry 2001;62:789-796. (Pubitemid 33104665)
9. Mellman TA, David D, Barza L. Nefazodone treatment and dream reports in chronic PTSD. Depress Anxiety 1999;9:146-148. (Pubitemid 29239580)
10. Parsons MJ, D'Souza UM, Arranz MJ, et al. The -1438A/G polymorphism in the 5-hydroxytryptamine type 2A receptor gene affects promoter activity. Biol Psychiatry 2004;56:406-410.
11. Bonnier B, Gorwood P, Hamon M, et al. Association of 5-HT(2A) receptor gene polymorphism with major affective disorders: the case of a subgroup of bipolar disorder with low suicide risk. Biol Psychiatry 2002;51:762-765. (Pubitemid 34450812)
12. Enoch MA, Goldman D, Barnett R, et al. Association between seasonal affective disorder and the 5-HT2A promoter polymorphism, -1438G/A. Mol Psychiatry 1999;4:89-92. (Pubitemid 29050208)
13. Arranz MJ, Munro J, Sham P, et al. Meta-analysis of studies on genetic variation in 5-HT2A receptors and clozapine response. Schizophr Res 1998;32:93-99. (Pubitemid 28364714)
14. Li D, Duan Y, He L. Association study of serotonin 2A receptor (5-HT2A) gene with schizophrenia and suicidal behavior using systematic meta-analysis. Biochem Biophys Res Commun 2006;340:1006-1015. (Pubitemid 43053926)
15. Bernal M, Haro JM, Bernert S, et al. Risk factors for suicidality in Europe: results from the ESEMED study. J Affect Disord 2007;101:27-34. (Pubitemid 46887612)
16. Caspi A, Sugden K, Moffitt TE, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003;301:386-389. (Pubitemid 36877077)
17. Risch N, Herrell R, Lehner T, et al. Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. J Am Med Assoc 2009;301:2462-2471.
18. Munafo MR, Brown SM, Hariri AR. Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. Biol Psychiatry 2008;63:852-857.
19. Liberzon I, Sripada CS. The functional neuroanatomy of PTSD: a critical review. Prog Brain Res 2008;167:151-169. (Pubitemid 350123231)
20. Lee HJ, Lee MS, Kang RH, et al. Influence of the serotonin transporter promoter gene polymorphism on susceptibility to posttraumatic stress disorder. Depress Anxiety 2005;21:135-139. (Pubitemid 41040636)
21. Kilpatrick DG, Koenen KC, Ruggiero KJ, et al. The serotonin transporter genotype and social support and moderation of posttraumatic stress disorder and depression in hurricane-exposed adults. Am J Psychiatry 2007;164:1693-1699.
22. Koenen KC, Aiello AE, Bakshis E, et al. Modification of the association between serotonin transporter genotype and risk of posttraumatic stress disorder in adults by county-level social environment. Am J Epidemiol 2009;169:704-711.
23. Grabe HJ, Spitzer C, Schwahn C, et al. Serotonin transporter gene (SLC6A4) promoter polymorphisms and the susceptibility to posttraumatic stress disorder in the general population. Am J Psychiatry 2009;166:926-933.
24. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). J Am Med Assoc 2003;289:3095-3105. (Pubitemid 37432885)
25. Jonas BS, Brody D, Roper M, et al. Prevalence of mood disorders in a national sample of young American adults. Soc Psychiatry Psychiatr Epidemiol 2003;38:618-624. (Pubitemid 37455649)
26. Regier DA, Farmer ME, Rae DS, et al. One-month prevalence of mental disorders in the United States and sociodemographic characteristics: the epidemiologic catchment area study. Acta Psychiatr Scand 1993;88:35-47.
27. Breslau J, Aguilar-Gaxiola S, Kendler KS, et al. Specifying raceethnic differences in risk for psychiatric disorder in a USA national sample. Psychol Med 2006;36:57-68. (Pubitemid 41825346)
28. Breslau N, Kessler RC, Chilcoat HD, et al. Trauma and posttraumatic stress disorder in the community: the 1996 Detroit Area Survey of Trauma. Arch Gen Psychiatry 1998;55:626-632.
29. Lotrich FE, Pollock BG, Ferrell RE. Serotonin transporter promoter polymorphism in African Americans: allele frequencies and implications for treatment. Am J Pharmacogenomics 2003;3:145-147.
30. Roy A, Hu XZ, Janal MN, et al. Interaction between childhood trauma and serotonin transporter gene variation in suicide. Neuropsychopharmacol 2007;32:2046-2052. (Pubitemid 47258524)
31. Hu X, Oroszi G, Chun J, et al. An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk. Alcohol Clin Exp Res 2005;29:8-16. (Pubitemid 40129206)
32. Alim TN, Graves E, Mellman TA, et al. Trauma exposure, posttraumatic stress disorder and depression in an African-American primary care population. J Natl Med Assoc 2006;98:1630-1636. (Pubitemid 44682958)
33. Weathers FW, Keane TM, Davidson JR. Clinician-administered PTSD scale: a review of the first ten years of research. Depress Anxiety 2001;13:132-156.
34. First MB, Spitzer R-L, Gibbon M, et al. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition With Psychotic Screen (SCID-I/P W/PSY SCREEN). New York: Biometrics Research, New York State Psychiatric Institute; 2002.
35. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003;19:149-150.
36. Zuo J, Liu Z, Ouyang X, et al. Distinct neurobehavioral consequences of prenatal exposure to sulpiride (SUL) and risperidone (RIS) in rats. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:387-397. (Pubitemid 351187831)
37. Larisch R, Klimke A, Mayoral F, et al. Disturbance of serotonin 5HT2 receptors in remitted patients suffering from hereditary depressive disorder. Nuklearmedizin 2001;40:129-134. (Pubitemid 32827351)
38. Biver F, Lotstra F, Monclus M, et al. Sex difference in 5HT2 receptor in the living human brain. Neurosci Lett 1996;204:25-28. (Pubitemid 26053669)